Bangalore-based Sobha Developers had a two-fold rise in its net profit to Rs 34.3 crore (Rs 343 million) in the April-June quarter. J C Sharma, Managing Director, spoke to Business Standard on the revival in demand and the company's growth plans.
While financial institutions like banks not showing interest in investing in basic biotechnology research as they have long gestation periods, PE and VC funds too are not comfortable betting their money on research projects as they do not give an opportunity for a quick exit facility.
Anti-diabetic drug makers are looking to launch cheaper drugs targeting patients in rural areas.
S (Kris) Gopalakrishnan speaks on the outlook for Infosys and the sector.
RBI recently hiked the repo and reverse repo rates by 25 basis points to check the spiraling inflation in the country. Any further rate hike is also expected as the RBI has hinted to do so in order to suck excess liquidity from the market.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances